OxSonics Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

OxSonics Therapeutics General Information

Description

Operator of a therapeutics platform intended to develop an anti-cancer therapy to improve the delivery of agents to tumors by disrupting their structure. The company's platform combines particles that are co-administered independently with a drug and actively manages the delivery of oncology drugs into solid tumors, and requires no drug reformulation, enabling healthcare providers to create a localized pumping effect that increases the delivery and penetration of the therapeutics throughout the tumor.

Contact Information

Website
www.oxsonics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Magdalen Centre, Oxford Science Park
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Drug Discovery
Biotechnology
Vertical(s)
SaaS, HealthTech, Life Sciences, Oncology
Corporate Office
  • The Magdalen Centre, Oxford Science Park
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OxSonics Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Oct-2025 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series B2) 01-Jul-2020 Completed Clinical Trials - Phase 2
6. Early Stage VC (Series B) 09-Jan-2017 Completed Pre-Clinical Trials
5. Early Stage VC (Series A) 28-Jul-2014 Completed Pre-Clinical Trials
4. Grant 16-Jun-2014 Completed Pre-Clinical Trials
3. Capitalization 01-Jan-2014 Completed Pre-Clinical Trials
2. Early Stage VC 01-Jan-2014 $491K $491K Completed Startup
1. University Spin-Out 03-Jul-2013 Completed Startup
To view OxSonics Therapeutics’s complete valuation and funding history, request access »

OxSonics Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view OxSonics Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

OxSonics Therapeutics Patents

  • 60

    Total Documents Applications and Grants

  • Total Patents Families

  • 38

    Granted

  • 9

    Pending

  • Expiring in next 12 mo

OxSonics Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4661764-A1 Monitoring drug delivery Pending 10-Feb-2023
GB-202301928-D0 Monitoring drug delivery Inactive 10-Feb-2023
US-20260041899-A1 Monitoring drug delivery Pending 10-Feb-2023
WO-2024165870-A1 Monitoring drug delivery Inactive 10-Feb-2023
EP-4389112-A1 Cavitation-inducing biodegradable polymeric particles Pending 23-Dec-2022 A61K9/0009
To view OxSonics Therapeutics’s complete patent history, request access »

OxSonics Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OxSonics Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anjost Investment Family Office Minority
Perivoli Innovations Venture Capital Minority
University of Oxford Endowment Limited Partner Minority
Winton Ventures Venture Capital Minority
Longwall Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

OxSonics Therapeutics FAQs

  • When was OxSonics Therapeutics founded?

    OxSonics Therapeutics was founded in 2013.

  • Where is OxSonics Therapeutics headquartered?

    OxSonics Therapeutics is headquartered in Oxford, United Kingdom.

  • What is the size of OxSonics Therapeutics?

    OxSonics Therapeutics has 15 total employees.

  • What industry is OxSonics Therapeutics in?

    OxSonics Therapeutics’s primary industry is Drug Delivery.

  • Is OxSonics Therapeutics a private or public company?

    OxSonics Therapeutics is a Private company.

  • What is OxSonics Therapeutics’s current revenue?

    The current revenue for OxSonics Therapeutics is .

  • How much funding has OxSonics Therapeutics raised over time?

    OxSonics Therapeutics has raised $30.2M.

  • Who are OxSonics Therapeutics’s investors?

    Anjost Investment, Perivoli Innovations, University of Oxford Endowment, Winton Ventures, and Longwall Ventures are 5 of 10 investors who have invested in OxSonics Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process